» Authors » Glenn Kunnath Bonney

Glenn Kunnath Bonney

Explore the profile of Glenn Kunnath Bonney including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 539
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tijore A, Margadant F, Dwivedi N, Morgan L, Yao M, Hariharan A, et al.
Bioeng Transl Med . 2025 Mar; 10(2):e10737. PMID: 40060768
Recent studies show that tumor cells undergo apoptosis after mechanical stretching, which promotes normal cell growth. Since ultrasound can produce similar sub-cellular mechanical stresses on the nanoscale, here we test...
2.
Wu A, Mohan R, Fong K, Chen Z, Bonney G, Kow A, et al.
Langenbecks Arch Surg . 2023 Aug; 408(1):317. PMID: 37587225
Background: Reducing clinically relevant post-operative pancreatic fistula (CR-POPF) incidence after pancreatic resections has been a topic of great academic interest. Optimizing post-operative drain management is a potential strategy in reducing...
3.
Chong S, Wang X, van Bloois L, Huang C, Syeda N, Zhang S, et al.
J Control Release . 2023 Jul; 360:344-364. PMID: 37406819
Atherosclerosis is a chronic inflammatory vascular disease that is characterized by the accumulation of lipids and immune cells in plaques built up inside artery walls. Docosahexaenoic acid (DHA, 22:6n-3), an...
4.
Law J, Tan C, Tan K, Gao Y, Pang N, Bonney G, et al.
Transplant Direct . 2023 May; 9(6):e1486. PMID: 37250490
Methods: Our center systematically introduced a laparoscopic hepatectomy program in 2006. We started with minor wedge resections followed by major hepatectomies with increasing complexities. In 2017, we performed our first...
5.
Xu J, Zheng M, Thng D, Toh T, Zhou L, Bonney G, et al.
ACS Sens . 2023 May; 8(5):1989-1999. PMID: 37129234
Spalt-like transcription factor 4 (SALL4) is an oncofetal protein that has been identified to drive cancer progression in hepatocellular carcinoma (HCC) and hematological malignancies. Furthermore, a high SALL4 expression level...
6.
Thng D, Hooi L, Toh C, Lim J, Rajagopalan D, Syariff I, et al.
Mol Oncol . 2023 Mar; 17(11):2275-2294. PMID: 36896891
Hepatocellular carcinoma (HCC) is the third deadliest and sixth most common cancer in the world. Histone-lysine N-methyltransferase EHMT2 (also known as G9a) is a histone methyltransferase frequently overexpressed in many...
7.
Thng D, Toh T, Pigini P, Hooi L, Dan Y, Chow P, et al.
Bioeng Transl Med . 2023 Jan; 8(1):e10363. PMID: 36684069
Deregulation of MYC is among the most frequent oncogenic drivers in hepatocellular carcinoma (HCC). Unfortunately, the clinical success of MYC-targeted therapies is limited. Synthetic lethality offers an alternative therapeutic strategy...
8.
Yeow M, Pang N, Muthiah M, Soon G, Yock-Young D, Bonney G, et al.
ANZ J Surg . 2022 Jul; 92(7-8):1867-1872. PMID: 35779018
Background: Evidence for use of graft from older donors in living donor liver transplantation (LDLT) has been conflicting. This study aims to clarify the impact of donor age on recipient...
9.
Chan J, Zhang B, Chew X, Salhi A, Kwok Z, Lim C, et al.
Nat Cell Biol . 2022 May; 24(6):928-939. PMID: 35618746
Most mammalian genes generate messenger RNAs with variable untranslated regions (UTRs) that are important post-transcriptional regulators. In cancer, shortening at 3' UTR ends via alternative polyadenylation can activate oncogenes. However,...
10.
Yeow M, Bonney G, Kow W, Wee P, Madhavan K, Iyer S
Transplantation . 2022 Apr; 106(5):895-897. PMID: 35470351
No abstract available.